$AMRN - gone up to $4.03 from $2.80 in less than 2 weeks - yet, no one is talking here - imo, AMRN will skyrocket IF interim Vascepa REDUCE-IT data is good .. data any-day in 3Q .. full data 1Q 2018
Vascepa REDUCE-IT outcomes trial
High Triglycerides With Mixed Dyslipidemia
data due by or around: 09/30/2017 (any-day)
Interim analysis announced September 12, 2016 - trial to proceed. Second interim analysis due 3Q 2017. Final data due mid-2018.
°°° (\__/) (\_(\ ° ° °
°°° (='.'=) (=' :') °°°
°°° (")_(") (,(')(')°°°
°°° °°° °°° °°° °°°